Study subjects
terminal cancer
TERMINAL CANCER
This study is a randomized controlled trial (parallel design). 100 patients with terminal cancer hospitalised in the oncology department of our hospital was selected to participate in this study. This study adheres to CONSORT guidelines. Participants were randomly assigned to different groups by a fixed researcher. The subjects were numbered according to the order of admission time and divided into a control group and an intervention group according to a random number table.First, number 100 patients from 1 to 100. Then look up the random number table, start from any row and any column in the random number table, read 3 digits as a random number, and correspond the random number with the number. Then all the selected random numbers are numbered from small to large (1-100). We specify that the control group is numbered 1 ~ 50, and the intervention group is numbered 51 ~ 100. Finally, 84 patients completed the study, with 42 cases in each group.The sample size calculation formula is as follows: n = Z 
Participant flow chart